PT1753431E - Composições farmacêuticas compreendendo zd6474 - Google Patents

Composições farmacêuticas compreendendo zd6474 Download PDF

Info

Publication number: PT1753431E
Authority: PT; Portugal
Prior art keywords: pharmaceutical compositions; diluent; pharmaceutically acceptable; pharmaceutical composition; acceptable salt
Prior art date: 2004-05-21

Application number

PT05744858T

Other languages

English (en)

Inventor

Paul William Stott

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-21

Filing date

2005-05-18

Publication date

2009-10-14

2005-05-18 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2009-10-14 Publication of PT1753431E publication Critical patent/PT1753431E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PT05744858T 2004-05-21 2005-05-18 Composições farmacêuticas compreendendo zd6474 PT1753431E (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0411378.3A GB0411378D0 (en)	2004-05-21	2004-05-21	Pharmaceutical compositions

Publications (1)

Publication Number	Publication Date
PT1753431E true PT1753431E (pt)	2009-10-14

Family

ID=32607743

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT05744858T PT1753431E (pt)	2004-05-21	2005-05-18	Composições farmacêuticas compreendendo zd6474

Country Status (33)

Country	Link
US (1)	US8067427B2 (pt)
EP (1)	EP1753431B1 (pt)
JP (1)	JP4740947B2 (pt)
KR (1)	KR101192935B1 (pt)
CN (1)	CN101031303B (pt)
AR (2)	AR049059A1 (pt)
AT (1)	ATE439841T1 (pt)
AU (1)	AU2005244650B2 (pt)
BR (1)	BRPI0511253B8 (pt)
CA (1)	CA2565513C (pt)
CY (1)	CY1109500T1 (pt)
DE (1)	DE602005016105D1 (pt)
DK (1)	DK1753431T3 (pt)
ES (1)	ES2330025T3 (pt)
GB (1)	GB0411378D0 (pt)
HR (1)	HRP20090547T1 (pt)
IL (1)	IL178928A (pt)
ME (2)	ME01505B (pt)
MX (1)	MXPA06013501A (pt)
MY (1)	MY138868A (pt)
NO (1)	NO338324B1 (pt)
NZ (1)	NZ550931A (pt)
PL (1)	PL1753431T3 (pt)
PT (1)	PT1753431E (pt)
RS (1)	RS51112B (pt)
RU (1)	RU2383343C2 (pt)
SA (1)	SA05260133B1 (pt)
SI (1)	SI1753431T1 (pt)
TW (1)	TWI355269B (pt)
UA (1)	UA81732C2 (pt)
UY (1)	UY28901A1 (pt)
WO (1)	WO2005112934A1 (pt)
ZA (1)	ZA200609110B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2278511B1 (es) *	2005-07-28	2008-06-16	Laboratorios Almirall S.A.	Comprimidos con perfil de disolucion mejorado.
CN105659085B (zh)	2013-08-28	2018-12-07	中美冠科生物技术（太仓）有限公司	预测受试者对多激酶抑制剂的反应的基因表达标志及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9718972D0 (en)	1996-09-25	1997-11-12	Zeneca Ltd	Chemical compounds
KR100881105B1 (ko) *	1999-11-05	2009-02-02	아스트라제네카 아베	Ｖｅｇｆ 억제제로서의 퀴나졸린 유도체
GB0001621D0 (en) *	2000-01-26	2000-03-15	Astrazeneca Ab	Pharmaceutical compositions
KR100419555B1 (ko) *	2000-05-29	2004-02-19	주식회사유한양행	비형간염바이러스의 에스-표면항원을 인식하는단일클론항체의 가변영역 및 이를 코딩하는 유전자
GB0126879D0 (en) *	2001-11-08	2002-01-02	Astrazeneca Ab	Combination therapy
AU2003211594A1 (en)	2002-03-05	2003-09-16	Eisai Co., Ltd.	Antitumor agent comprising combination of sulfonamide-containing heterocyclic compound with angiogenesis inhibitor

2004
- 2004-05-21 GB GBGB0411378.3A patent/GB0411378D0/en not_active Ceased
2005
- 2005-05-09 TW TW094114935A patent/TWI355269B/zh not_active IP Right Cessation
- 2005-05-17 UY UY28901A patent/UY28901A1/es unknown
- 2005-05-18 AT AT05744858T patent/ATE439841T1/de active
- 2005-05-18 UA UAA200613289A patent/UA81732C2/ru unknown
- 2005-05-18 PL PL05744858T patent/PL1753431T3/pl unknown
- 2005-05-18 ME MEP-2013-50A patent/ME01505B/me unknown
- 2005-05-18 PT PT05744858T patent/PT1753431E/pt unknown
- 2005-05-18 BR BRPI0511253A patent/BRPI0511253B8/pt active IP Right Grant
- 2005-05-18 WO PCT/GB2005/001931 patent/WO2005112934A1/en not_active Ceased
- 2005-05-18 DE DE602005016105T patent/DE602005016105D1/de not_active Expired - Lifetime
- 2005-05-18 KR KR1020067026603A patent/KR101192935B1/ko not_active Expired - Lifetime
- 2005-05-18 HR HR20090547T patent/HRP20090547T1/xx unknown
- 2005-05-18 RS RSP-2009/0458A patent/RS51112B/sr unknown
- 2005-05-18 ME MEP-2009-458A patent/ME02778B/me unknown
- 2005-05-18 JP JP2007517415A patent/JP4740947B2/ja not_active Expired - Lifetime
- 2005-05-18 ES ES05744858T patent/ES2330025T3/es not_active Expired - Lifetime
- 2005-05-18 SI SI200530793T patent/SI1753431T1/sl unknown
- 2005-05-18 NZ NZ550931A patent/NZ550931A/en not_active IP Right Cessation
- 2005-05-18 DK DK05744858T patent/DK1753431T3/da active
- 2005-05-18 US US11/596,979 patent/US8067427B2/en active Active
- 2005-05-18 CA CA2565513A patent/CA2565513C/en not_active Expired - Lifetime
- 2005-05-18 EP EP05744858A patent/EP1753431B1/en not_active Expired - Lifetime
- 2005-05-18 MX MXPA06013501A patent/MXPA06013501A/es active IP Right Grant
- 2005-05-18 AU AU2005244650A patent/AU2005244650B2/en active Active
- 2005-05-18 RU RU2006145357/15A patent/RU2383343C2/ru active Protection Beyond IP Right Term
- 2005-05-18 CN CN2005800162448A patent/CN101031303B/zh not_active Expired - Lifetime
- 2005-05-18 SA SA05260133A patent/SA05260133B1/ar unknown
- 2005-05-19 MY MYPI20052271A patent/MY138868A/en unknown
- 2005-05-20 AR ARP050102087A patent/AR049059A1/es not_active Application Discontinuation
2006
- 2006-10-29 IL IL178928A patent/IL178928A/en active IP Right Grant
- 2006-11-01 ZA ZA200609110A patent/ZA200609110B/en unknown
- 2006-12-12 NO NO20065735A patent/NO338324B1/no not_active IP Right Cessation
2009
- 2009-10-15 CY CY20091101075T patent/CY1109500T1/el unknown
2017
- 2017-11-09 AR ARP170103128A patent/AR110045A2/es unknown

Also Published As

Publication number	Publication date
GB0411378D0 (en)	2004-06-23
CN101031303B (zh)	2011-08-31
AR049059A1 (es)	2006-06-21
US20070244323A1 (en)	2007-10-18
NO20065735L (no)	2006-12-19
RU2383343C2 (ru)	2010-03-10
RU2006145357A (ru)	2008-06-27
WO2005112934A1 (en)	2005-12-01
BRPI0511253A (pt)	2007-11-27
ATE439841T1 (de)	2009-09-15
NZ550931A (en)	2009-05-31
CY1109500T1 (el)	2014-08-13
MXPA06013501A (es)	2007-06-12
ZA200609110B (en)	2008-06-25
UY28901A1 (es)	2005-12-30
TW200612953A (en)	2006-05-01
CN101031303A (zh)	2007-09-05
RS51112B (sr)	2010-10-31
SI1753431T1 (sl)	2009-12-31
SA05260133B1 (ar)	2008-12-23
ME02778B (me)	2010-10-31
BRPI0511253B8 (pt)	2021-05-25
ES2330025T3 (es)	2009-12-03
HRP20090547T1 (hr)	2009-11-30
CA2565513C (en)	2010-10-19
AR110045A2 (es)	2019-02-20
AU2005244650B2 (en)	2008-04-10
EP1753431B1 (en)	2009-08-19
US8067427B2 (en)	2011-11-29
EP1753431A1 (en)	2007-02-21
NO338324B1 (no)	2016-08-08
KR101192935B1 (ko)	2012-10-18
HK1099220A1 (en)	2007-08-10
DK1753431T3 (da)	2009-11-16
MY138868A (en)	2009-08-28
DE602005016105D1 (de)	2009-10-01
IL178928A (en)	2012-04-30
CA2565513A1 (en)	2005-12-01
UA81732C2 (ru)	2008-01-25
PL1753431T3 (pl)	2009-12-31
IL178928A0 (en)	2007-03-08
BRPI0511253B1 (pt)	2020-03-31
KR20070034499A (ko)	2007-03-28
AU2005244650A1 (en)	2005-12-01
TWI355269B (en)	2012-01-01
JP2007538060A (ja)	2007-12-27
JP4740947B2 (ja)	2011-08-03
ME01505B (me)	2014-04-20

Publication	Publication Date	Title
MXPA05005709A (es)	2005-08-16	Composiciones farmaceuticas que comprenden un compuesto farmacologico basico respectivamente acido, un agente tensioactivo y un acido hidrosoluble fisiologicamente tolerable respectivamente base.
WO2007019439A3 (en)	2007-05-03	Block copolymer compositions and uses thereof
EP2261236A3 (en)	2011-09-14	Composition for proteasome inhibition
MX2009004965A (es)	2009-06-05	Formas de dosificacion y co-administracion de un agonista de opioides y un antagonista de opioides.
WO2006007448A3 (en)	2007-10-25	Pharmaceutical co-crystal compositions and related methods of use
TW200716119A (en)	2007-05-01	A solid pharmaceutical dosage formulation
WO2006020994A3 (en)	2006-07-20	Compositions and methods using hyaluronic acid and hyluronidase inhibitors
GEP20074047B (en)	2007-02-26	Pramipexole once-daily dosage form
GEP20094666B (en)	2009-04-10	Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
UA93709C2 (ru)	2011-03-10	12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
MX2008002492A (es)	2008-04-03	Composiciones farmaceuticas que comprenden un farmaco dependiente del ph, un modificador del ph, y un agente retardante.
TW200531686A (en)	2005-10-01	Pharmaceutical compositions
EP2332526A3 (en)	2011-10-12	Combination of a renin-inhibitor and an anti-dyslipidemic agent and/or an antiobesity agent
GB0001315D0 (en)	2000-03-08	Organic compounds
GB0411378D0 (en)	2004-06-23	Pharmaceutical compositions
ZA200604874B (en)	2007-03-28	Pharmaceutical compositions
AU2003281468A1 (en)	2004-02-09	P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
MY138799A (en)	2009-07-31	Orodispersible pharmaceutical composition of an antithrombotic compound
WO2005105135A8 (en)	2006-12-07	Il-6 for therapy or prevention of chemotherapy-induced neuropathy
PL1682122T3 (pl)	2008-09-30	Kombinacja walsartanu, amiloridu lub triamterenu i diuretyka
WO2006004903A3 (en)	2006-05-04	1,2-bis-(substituted-phenyl)-2-propen-1-ones and pharmaceutical compositions thereof
WO2005035746A3 (en)	2005-06-23	Medical use of tbk-1 or of inhibitors thereof
EA200970167A1 (ru)	2009-08-28	Фармацевтическая композиция, содержащая комбинацию саредутанта и селективного ингибитора обратного захвата серотонина или ингибитора обратного захвата серотонина/норэпинефрина
WO2004111088A3 (en)	2005-02-10	Angiogenic factor and inhibitors thereof
TW200630119A (en)	2006-09-01	Novel compositions